Announcing New frontiers in synthetic chemistry 2024.
Connect with the #SyntheticChemistry community and discuss recent advances at New frontiers in synthetic chemistry, organised with @AstraZeneca.
Find out more: https://t.co/DiAz5vU1Fw
Holy Smokes, the Marsh Family has put out this parody song about J.D. Vance and not only is it catchy but it hits the nail on the head…
“Anti Trump a few years ago,
Called him out as a ‘Hitler’ show.
Now you’re playing his sidekick,
Kissing Donald’s ring”
I watched it 70 times.
@MarshSongs
⚗️Explore our newest Special Issue, focused on the first deliveries of sufficient amounts of an active pharmaceutical ingredient (API) to support clinical studies. Read the latest research on this pivotal stage in drug development: https://t.co/IQ9mZ3CPSt
Art by @marcmakescomics
Today's special issue of #OPRD focuses on the first deliveries of sufficient amounts of an active pharmaceutical ingredient (API) to support clinical studies.
Shout-out to Marc Jackson (@MARCmakescomics) for the front cover!
Read the new issue here! https://t.co/O9lcyMj3Hq
Now online:
News & Views on the Article by @Isotope_Effect@WillGoRow@FlitschSabine & co-workers @UoMMIB
https://t.co/BtGa46f93a
Horner–Wadsworth–Emmons olefination for bioconjugation by Yimon Aye @EPFL_en
https://t.co/7XCQouhc8B ($)
Now online & open access:
Article by @Isotope_Effect, @WillGoRow, @FlitschSabine & co-workers @UoMMIB
Horner–Wadsworth–Emmons olefination of proteins and glycoproteins
https://t.co/BtGa46f93a
Goundry (@WillGoRow) and coworkers from AstraZeneca have reported the first and second generation synthesis of TOPO 1 inhibitor AZ14170133 for use as an ADC Payload. They doubled the yield and reduced the PMI by 66%! Check it out here: https://t.co/YEJ1nq4pvW